New research indicates that Medicare patients were more likely to continue using opioid painkillers a year after a visit to the emergency department if they had been treated there by a physician that frequently prescribes opioids.
Medicare patients are more likely to continue using opioid painkillers a year after a visit to the emergency department (ED) if they had been treated there by a physician that frequently prescribes opioids, according to new research.
As part of efforts to identify drivers of the opioid abuse epidemic in America, prior research has demonstrated that rates of opioid prescriptions vary greatly by state. In 2012, for instance, the prescribing rate in Alabama, the highest-prescribing state, was 2.7 times higher than the rate in Hawaii, the lowest-prescribing state.
However, a recent study in the New England Journal of Medicine investigated whether physician-level prescribing patterns have an effect on long-term opioid abuse outcomes. Researchers collected claims data from Medicare beneficiaries who were prescribed an opioid during an ED visit and examined their likelihood of long-term opioid use 12 months after the visit.
The ED physicians who treated the sample patients were separated into quartiles based on the proportion of visits leading to an opioid prescription being filled, yielding groups of “high-intensity” prescribers in the top quartile and “low-intensity” prescribers in the bottom quartile. They were also classified by the median dose of opioids they prescribed during emergency visits.
Patient characteristics and diagnoses were similar whether treated by high-intensity and low-intensity prescribers; selection bias was not a concern as patients generally do not choose which physician will treat them in the ED. Within the same hospital, opioid prescribing rates varied significantly between the high-intensity prescribers, who prescribed opioids at 24.1% of visits, and the low-intensity prescribers, with a rate of just 7.3%.
The main outcome of the study was whether patients continued to use opioids long-term at 12 months after the initial emergency visit. As the study authors predicted, patients were more likely to experience long-term use if they had been treated by high-intensity prescribers. Those seen by the physicians in the highest quartile had an adjusted odds ratio for long-term use of 1.30 compared with the lowest-intensity quartile. These patients also had significantly higher rates of hospital encounters related to opioids and falls or fractures in the 12 months following their emergency visit. Furthermore, long-term opioid use was more common among patients treated by high dose-intensity prescribers.
The researchers acknowledged that their study could not assess whether the opioids were prescribed appropriately or were in fact unnecessary. However, their findings raised concerns about excessive prescribing in the ED, especially given the risks of long-term opioid use.
“These results suggest that an increased likelihood of receiving an opioid for even one encounter could drive clinically significant future long-term opioid use and potentially increased adverse outcomes among the elderly,” they concluded.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen